Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Microbial mechanisms to improve immune checkpoint blockade responsiveness

Neoplasia(2022)10.1016/j.neo.2022.100818Source: DataRank Database

Microbial mechanisms to improve immune checkpoint blockade responsiveness is a research paper published in Neoplasia (2022). On theSindex it has a DataRank of 0. It has been cited 24 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access24 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 1.86)OA: goldTopics (53)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Howard C. Hang ORCID,Matthew E. Griffin ORCID

Live enrichment

PubMed:35816968 PMC:PMC9284443 OpenAlex:https://openalex.org/W4284958112

National Cancer Institute

Grant: 5R01CA245292

Hope Funds for Cancer Research

Grant: HCFR-19-03-02

NIAID NIH HHS

Grant: R21 AI156674

NCI NIH HHS

Grant: R01 CA245292

National Institutes of Health

Grant: 7R01CA245292-03

Translation of commensal bacteria mechanism for immunotherapy

Melanoma Research Foundation

National Institutes of Health

FWCI

1.86

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://www.sciencedirect.com/science/article/pii/S1476558622000458/pdf

publisherhttps://www.sciencedirect.com/science/article/pii/S1476558622000458/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1476558622000458?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1476558622000458?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.neo.2022.100818

Fields of Study

Cancer Immunotherapy and BiomarkersGut microbiota and healthTryptophan and brain disorders0301 basic medicine03 medical and health sciences0303 health sciencesHumansImmune Checkpoint InhibitorsImmunotherapyMicrobiotaNeoplasms

MeSH Terms

Immune Checkpoint InhibitorsHumansImmunotherapyNeoplasmsMicrobiota

Keywords

BiologyContext (archaeology)Immune checkpointComputational biologyImmune systemLimitingCancerBlockadeMicrobiomeBioinformaticsImmunotherapyImmunologyGeneticsCancer ImmunotherapyGut MicrobiotaMicrobial MetabolitesCheckpoint InhibitorOriginal articleOncology and CarcinogenesisClinical SciencesVaccine RelatedClinical ResearchNeoplasms2.1 Biological and endogenous factorsHumansOncology & CarcinogenesisAetiologyImmune Checkpoint InhibitorsRC254-282Biomedical and Clinical SciencesInflammatory and immune systemMicrobiotaHuman GenomeNeoplasms. Tumors. Oncology. Including cancer and carcinogensGood Health and Well Being5.1 PharmaceuticalsDevelopment of treatments and therapeutic interventions

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Microbial mechanisms to improve immune checkpoint blockade responsiveness

FAIR Checklist

Authors (2)

Funding (7 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)